Prime Medicine (PRME) Deferred Taxes (2021 - 2024)

Prime Medicine (PRME) has 4 years of Deferred Taxes data on file, last reported at -$134000.0 in Q2 2024.

• Quarterly Deferred Taxes fell 532.26% year-over-year to -$134000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was -$134000.0 (down 335.09% YoY) and the FY2023 annual result came in at -$279000.0, up 71.06% from the prior year.
• Deferred Taxes slipped to -$134000.0 in Q2 2024, from $134000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $1.2 million in Q4 2021 to a low of -$532000.0 in Q1 2022.
• A 4-year average of $0.0 and a median of -$121000.0 in 2023 frame the typical range for Deferred Taxes.
• The widest YoY moves for Deferred Taxes: up 166.34% in 2024, down 532.26% in 2024.
• Tracing PRME's Deferred Taxes over 4 years: stood at $1.2 million in 2021, then sank by 116.25% to -$202000.0 in 2022, then soared by 46.53% to -$108000.0 in 2023, then decreased by 24.07% to -$134000.0 in 2024.
• The last three Deferred Taxes figures came in at -$134000.0 (Q2 2024), $134000.0 (Q1 2024), and -$108000.0 (Q3 2023), per Business Quant data.